COMMUNIQUÉS West-GlobeNewswire

Tauriga Sciences, Inc. on Track to Up-List its Shares to OTCQB Exchange at Open of Trading on July 30, 2018
12/07/2018
NEW YORK, NY, July 12, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) (OTC PINK: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
WishBone Medical, Inc. announces Sanford S. Kunkel, M.D. joins Board of Advisors
12/07/2018
WARSAW, Ind., July 12, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. is pleased to announce that Sanford Kunkel, M.D. joins the WishBone Medical Board of Advisors. Dr. Kunkel has been a Consulting Surgeon for WishBone [...]
Catalyst Biosciences Announces Multiple Presentations at the Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis
12/07/2018
Conference call and webcast to be held Wednesday, July 18, 2018 at 8:30 a.m. EDT SOUTH SAN FRANCISCO, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage [...]
Altimmune Restructures Financing Agreement with Majority of the Remaining Series B Investors
12/07/2018
GAITHERSBURG, Md., July 12, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company focused on preventing infectious diseases, today announced it has entered into agreements [...]
CLS Holdings USA Provides an Update to the First Complete Year of Adult Use Cannabis in Nevada
12/07/2018
Total Sales and Tax Revenue Higher than Initial Forecasts LAS VEGAS, July 12, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and a [...]
Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial
12/07/2018
VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V:SBM) (FSE:ZSB) (the “ Company ”) announced today that partner, Jiangsu Wanbang Biopharmaceuticals (“Wanbang”), has confirmed [...]
Cue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
12/07/2018
CAMBRIDGE, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat [...]
HCi Viocare Rebrands Itself and Becomes Rafina Innovations Inc.
12/07/2018
Glasgow, Scotland, July 12, 2018 (GLOBE NEWSWIRE) -- HCi Viocare (OTCQB:VICA) , is pleased to announce that, further to our Current Report on Form 8-K filed June 15, 2018, HCi Viocare has completed a name change [...]
Managers' transactions
12/07/2018
Company Announcement No. 12/2018 12 July 2018 Attachment No 12 2018 US_Managers transactions
Zynerba Pharmaceuticals Announces New FAB-C Phase 2 Open-Label Data in Patients with Fragile X Syndrome
12/07/2018
- Significant Improvements in Behavioral Symptoms Observed in Patients and Sustained through 38 Weeks of Treatment with ZYN002 - - Presentation Today at the 16 th NFXF International Fragile X Conference - DEVON, Pa., [...]
Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California for Stroke IP; Second Pre-Clinical Collaboration Initiated to Test the Efficacy of AST-OPC1 for the Treatment of Stroke
12/07/2018
AST-OPC1 has Demonstrated Positive Safety Profile and Promising Signs of Efficacy in a Phase 1/2a Trial for Severe Spinal Cord Injury FREMONT, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. ( [...]
Xenon Pharmaceuticals Announces At-The-Market Equity Offering
12/07/2018
BURNABY, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, announced today that it has entered into an at-the-market equity [...]
Allergy Therapeutics PLC: Trading Update
12/07/2018
Allergy Therapeutics plc (“Allergy Therapeutics” or the “Group”) Trading update Group’s market share continues to grow 12 July 2018 Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology [...]
ProQR Announces Presentations on Programs in Ophthalmology at Conferences in July
12/07/2018
LEIDEN, the Netherlands, July 12, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe [...]
Microbix to Present at Okanagan Capital Conference
12/07/2018
Conference Introduces Growth Companies to Investors, July 12-14, 2018 TORONTO, July 12, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, [...]
Unum Therapeutics to Present Pre-Clinical Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the American Society of Hematology (ASH) Summit on Emerging Immunotherapies for Hematological Diseases
12/07/2018
CAMBRIDGE, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]
InMode Introduces Triton: The World’s First and Only Simultaneous Multi-Wavelength Hair Removal
12/07/2018
NEW YORK, July 12, 2018 (GLOBE NEWSWIRE) -- InMode Ltd., a manufacturer and distributor of medical-aesthetic technology to doctors around the world, is pleased to announce the launch and FDA clearance of the Triton hair [...]
Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
12/07/2018
Primary Endpoint Achieved - Statistically Significant Convulsive Seizure Reduction for ZX008 versus Placebo for Adjunctive Treatment of Seizures ZX008 Also Demonstrated Statistical Significance in All Key Secondary [...]
Auxly Announces Director Resignation
12/07/2018
VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") has announced today that following his appointment as Chief Executive Officer of a [...]

Pages